<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>春风健康 | wechat-feeds</title><link>http://MzI4NTI5NDU4OA.favicon.privacyhide.com/favicon.ico</link><description>中国临床研究服务领域的交流平台</description><managingEditor> (hellodword)</managingEditor><pubDate>Tue, 15 Jun 2021 19:15:12 +0800</pubDate><image><url>http://MzI4NTI5NDU4OA.favicon.privacyhide.com/favicon.ico</url><title>春风健康 | wechat-feeds</title><link>http://MzI4NTI5NDU4OA.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>【实体瘤招募】润新生物多靶点全新小分子Na+/K+-ATP酶抑制剂招募晚期恶性实体肿瘤患者​</title><link>https://mp.weixin.qq.com/s/_feez9x_OTlbqBJP4xxAqg</link><description></description><content:encoded><![CDATA[【实体瘤招募】润新生物多靶点全新小分子Na+/K+-ATP酶抑制剂招募晚期恶性实体肿瘤患者​]]></content:encoded><pubDate>Mon, 14 Jun 2021 17:26:00 +0800</pubDate></item><item><title>注意了，端午节饮食有禁忌！</title><link>https://mp.weixin.qq.com/s/-9zCGAVWzBkscjUycYdfjQ</link><description></description><content:encoded><![CDATA[注意了，端午节饮食有禁忌！]]></content:encoded><pubDate>Sun, 13 Jun 2021 16:50:31 +0800</pubDate></item><item><title>【肺癌招募】倍而达第三代EGFR-TKI抑制剂招募晚期非小细胞肺癌患者</title><link>https://mp.weixin.qq.com/s/A_lJXBBhll6Ayz0ipptNUQ</link><description></description><content:encoded><![CDATA[【肺癌招募】倍而达第三代EGFR-TKI抑制剂招募晚期非小细胞肺癌患者]]></content:encoded><pubDate>Sun, 13 Jun 2021 16:49:31 +0800</pubDate></item><item><title>得了癌症怎么治？2021年最新肿瘤治疗方案汇总</title><link>https://mp.weixin.qq.com/s/Ufg-j1lIoJYxAQoaR4uTvw</link><description></description><content:encoded><![CDATA[得了癌症怎么治？2021年最新肿瘤治疗方案汇总]]></content:encoded><pubDate>Fri, 11 Jun 2021 19:54:22 +0800</pubDate></item><item><title>呕吐、腹泻、脱发、口腔溃疡……一文应对化疗10大副作用，值得收藏！</title><link>https://mp.weixin.qq.com/s/4cIX4gtf9m75mKGc3d1ZjQ</link><description></description><content:encoded><![CDATA[呕吐、腹泻、脱发、口腔溃疡……一文应对化疗10大副作用，值得收藏！]]></content:encoded><pubDate>Thu, 10 Jun 2021 18:08:10 +0800</pubDate></item><item><title>CTLA-4+PD-1！信达双免疫疗法招募晚期肝细胞癌患者</title><link>https://mp.weixin.qq.com/s/CffcFPn1XdF5zD9w1bECzg</link><description></description><content:encoded><![CDATA[CTLA-4+PD-1！信达双免疫疗法招募晚期肝细胞癌患者]]></content:encoded><pubDate>Thu, 10 Jun 2021 17:58:29 +0800</pubDate></item><item><title>首款胆管癌靶向药，ASCO最新疗效数据令人惊喜！</title><link>https://mp.weixin.qq.com/s/-RG1oG7bDQN7bKHamtLYQw</link><description></description><content:encoded><![CDATA[首款胆管癌靶向药，ASCO最新疗效数据令人惊喜！]]></content:encoded><pubDate>Wed, 09 Jun 2021 17:08:09 +0800</pubDate></item><item><title>患者福音！罗氏T药招募三阴乳腺癌患者</title><link>https://mp.weixin.qq.com/s/Apm_qytqX82Vb3FMvKGY6A</link><description></description><content:encoded><![CDATA[患者福音！罗氏T药招募三阴乳腺癌患者]]></content:encoded><pubDate>Tue, 08 Jun 2021 17:59:19 +0800</pubDate></item><item><title>漫话“懒癌”，这种癌虽然慢，但也要重视起来</title><link>https://mp.weixin.qq.com/s/Fh7rln-JTLmugDqvkMgpzA</link><description></description><content:encoded><![CDATA[漫话“懒癌”，这种癌虽然慢，但也要重视起来]]></content:encoded><pubDate>Mon, 07 Jun 2021 13:43:36 +0800</pubDate></item><item><title>【肺癌招募】神州细胞抗VEGF抗体招募非小细胞肺癌患者</title><link>https://mp.weixin.qq.com/s/AhlU1QNLZ0s3JKEUAqUxPA</link><description></description><content:encoded><![CDATA[【肺癌招募】神州细胞抗VEGF抗体招募非小细胞肺癌患者]]></content:encoded><pubDate>Sun, 06 Jun 2021 17:08:58 +0800</pubDate></item></channel></rss>